Goldman Sachs Group Inc Mesoblast LTD Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

May 14, 2024
BUY
$2.73 - $3.7 $99,393 - $134,709
36,408 New
36,408 $105,000
Q4 2022

Feb 13, 2023
BUY
$2.73 - $3.7 $99,393 - $134,709
36,408 New
36,408 $105,000
Q1 2022

May 16, 2022
SELL
$3.58 - $4.98 $197,050 - $274,109
-55,042 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$4.17 - $7.09 $1,180 - $2,006
-283 Reduced 0.51%
55,042 $264,000
Q3 2021

Nov 10, 2021
BUY
$5.87 - $7.85 $324,757 - $434,301
55,325 New
55,325 $333,000

Others Institutions Holding MESO

# of Institutions
3
Shares Held
151K
Call Options Held
0
Put Options Held
0
View Full List

About MESOBLAST LTD

MESO Quotes by TradingView
  • Ticker MESO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 147,316,000
  • Market Cap $2.51B
  • Description
  • Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...
More about MESO
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email